ACS Sensors · 2020 · 57 citations · 29 references
EngineeringBiotechnologyCardiologyBiosensorsNanomaterialsSensorsCardiac BiomarkersClinical BiosensingNanomaterial-based BiosensorsNanosensorsOptical BiosensingOptical BiosensorsAcute Myocardial Infarction DiagnosisAntibody-based NanobiosensorsDisease BiomarkersHigh-sensitivity Troponin AssaysImmunoassay MethodologyMethod Detection LimitNanoparticle-based SensingNanoparticles
A rapid and sensitive method to detect cardiac troponin I (cTnI) in human blood is critical to the diagnosis and treatment of acute myocardial infarction (AMI). Here, we describe a simple one-step digital immunoassay for single-molecule detection without washing steps. A sample containing cTnI mixed with detection antibody-conjugated gold nanoparticles (AuNPs) is added to a capture antibody-coated sensor surface and the formation of the antibody-cTnI-antibody sandwich is detected by digitally counting the binding of the individual gold nanoparticles to the sensor surface in real time using a bright-field optical imaging setup together with a differential imaging algorithm. The digital immunoassay detects cTnI in undiluted human plasma, which achieves a detection limit of 5.7 ng/L within a detection time of only 10 min, which meets the requirement of current clinical high-sensitivity troponin assay (∼70 ng/L cutoff). We anticipate that the one-step and real-time digital immunoassay can be applied to the detection of other disease biomarkers in blood.
29
Forecasting the Future of Cardiovascular Disease in the United States
Paul A. Heidenreich, Justin G. Trogdon, Olga Khavjou et al. · Circulation · 2011 · 3.2K citations · Full text